Skip to Content Skip to Content

Health Sciences

Reset All Filters
2004 Results
New Penn Study Shows Drinking Alcohol, Even Light-to-Moderate Amounts, Provides No Heart Health Benefit

New Penn Study Shows Drinking Alcohol, Even Light-to-Moderate Amounts, Provides No Heart Health Benefit

Reducing the amount of alcoholic beverages consumed, even for light-to-moderate drinkers, may improve cardiovascular health, including a reduced risk of coronary heart disease, lower body mass index (BMI) and blood pressure, according to a new multi-center study published in The BMJ and co-led by the Pere

Katie Delach

Penn to Lead $22.5 Million Project on Restoring Memory Loss

Penn to Lead $22.5 Million Project on Restoring Memory Loss

A team of scientists and physicians at the University of Pennsylvania will lead a four-year effort worth as much as $22.5 million to develop next-generation technologies to restore memory function in people who suffer from memory loss due to disease or traumatic injury.

Evan Lerner

Penn Study: Computer-Automated, Time-Lapse Embryo Photography May Increase Success of In-Vitro Fertilization

Penn Study: Computer-Automated, Time-Lapse Embryo Photography May Increase Success of In-Vitro Fertilization

Using computer-automated, time-lapse photography of embryos in the laboratory during in-vitro fertilization may improve embryo selection, potentially increasing the chances of pregnancy among women undergoing the procedure, according to new research from the Perelman School of Medicine at the University of Pennsylvania and five other fertility centers.

Katie Delach

Major Gaps in Hepatitis C Care Identified As New Drugs and Screening Efforts Emerge, Penn Study Finds

Major Gaps in Hepatitis C Care Identified As New Drugs and Screening Efforts Emerge, Penn Study Finds

A new meta-analysis published online in PLOS ONE by infectious disease and epidemiology specialists from the Perelman School of Medicine at the University of Pennsylvania highlights significant gaps in hepatitis C care that will prove useful as the U.S. health care system continues to see an influx of patients with the disease because of improved screening efforts and new, promising drugs.

Steve Graff